<DOC>
	<DOCNO>NCT00231998</DOCNO>
	<brief_summary>Pimecrolimus , ascomycin derivative , anti-inflammatory non-steroidal agent . In study , long-term safety efficacy Pimecrolimus cream evaluate Japanese pediatric patient atopic dermatitis . This study 6-month extension study follow core study . THIS STUDY IS NOT ENROLLING PATIENTS IN THE UNITED STATES</brief_summary>
	<brief_title>Extension Study Pimecrolimus Cream Pediatric Patients With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patients complete core study whose participation study consider appropriate judged investigator Patients whose guardian give write informed consent participation study Patients fail treatment compliance core study Patients major violation protocol core study</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Atopic dermatitis , ASM981 , pimecrolimus</keyword>
</DOC>